| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 220 | 253 | 488 | 604 | 676 | 840 | 549 | 556 | 545 | 619 | 422 | 477 | |
Growth YoY Revenue Growth YoY% | -37.9 | -31.5 | 40.4 | 161.3 | 207.6 | 232.3 | 12.6 | -8.0 | -19.5 | -26.3 | -23.1 | -14.2 |
| 154 | 180 | 363 | 398 | 439 | 611 | 437 | 435 | 449 | 520 | 421 | 441 | |
| 66 | 73 | 125 | 205 | 237 | 229 | 112 | 121 | 95 | 99 | 1 | 35 | |
OPM OPM% | 30.1 | 29.0 | 25.6 | 34.0 | 35.1 | 27.3 | 20.4 | 21.8 | 17.5 | 15.9 | 0.3 | 7.4 |
| 14 | 17 | 19 | 16 | 22 | -4 | 6 | 16 | 1 | -18 | 12 | 12 | |
Interest Expense Interest ExpenseCr | 2 | 2 | 10 | 10 | 11 | 10 | 10 | 9 | 9 | 9 | 7 | 8 |
Depreciation DepreciationCr | 13 | 17 | 31 | 38 | 44 | 54 | 45 | 44 | 47 | 51 | 50 | 50 |
PBT PBTCr | 65 | 71 | 103 | 174 | 205 | 161 | 63 | 84 | 41 | 20 | -43 | -11 |
| 19 | 17 | 28 | 36 | 51 | 44 | 16 | 17 | 12 | 12 | 2 | -13 | |
| 47 | 53 | 75 | 138 | 153 | 117 | 46 | 66 | 29 | 8 | -45 | 2 | |
Growth YoY PAT Growth YoY% | -56.6 | -57.0 | -37.5 | 73.8 | 228.3 | 119.5 | -38.4 | -52.0 | -81.1 | -92.9 | -197.4 | -96.6 |
NPM NPM% | 21.3 | 21.1 | 15.4 | 22.9 | 22.7 | 13.9 | 8.4 | 11.9 | 5.3 | 1.3 | -10.7 | 0.5 |
| 1.8 | 2.1 | 2.0 | 3.6 | 4.0 | 3.2 | 1.3 | 1.9 | 1.0 | 0.5 | -0.6 | 0.4 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 220 | 253 | 488 | 604 | 676 | 840 | 549 | 556 | 545 | 619 | 422 | 477 | |
Growth YoY Revenue Growth YoY% | -37.9 | -31.5 | 40.4 | 161.3 | 207.6 | 232.3 | 12.6 | -8.0 | -19.5 | -26.3 | -23.1 | -14.2 |
| 154 | 180 | 363 | 398 | 439 | 611 | 437 | 435 | 449 | 520 | 421 | 441 | |
| 66 | 73 | 125 | 205 | 237 | 229 | 112 | 121 | 95 | 99 | 1 | 35 | |
OPM OPM% | 30.1 | 29.0 | 25.6 | 34.0 | 35.1 | 27.3 | 20.4 | 21.8 | 17.5 | 15.9 | 0.3 | 7.4 |
| 14 | 17 | 19 | 16 | 22 | -4 | 6 | 16 | 1 | -18 | 12 | 12 | |
Interest Expense Interest ExpenseCr | 2 | 2 | 10 | 10 | 11 | 10 | 10 | 9 | 9 | 9 | 7 | 8 |
Depreciation DepreciationCr | 13 | 17 | 31 | 38 | 44 | 54 | 45 | 44 | 47 | 51 | 50 | 50 |
PBT PBTCr | 65 | 71 | 103 | 174 | 205 | 161 | 63 | 84 | 41 | 20 | -43 | -11 |
| 19 | 17 | 28 | 36 | 51 | 44 | 16 | 17 | 12 | 12 | 2 | -13 | |
| 47 | 53 | 75 | 138 | 153 | 117 | 46 | 66 | 29 | 8 | -45 | 2 | |
Growth YoY PAT Growth YoY% | -56.6 | -57.0 | -37.5 | 73.8 | 228.3 | 119.5 | -38.4 | -52.0 | -81.1 | -92.9 | -197.4 | -96.6 |
NPM NPM% | 21.3 | 21.1 | 15.4 | 22.9 | 22.7 | 13.9 | 8.4 | 11.9 | 5.3 | 1.3 | -10.7 | 0.5 |
| 1.8 | 2.1 | 2.0 | 3.6 | 4.0 | 3.2 | 1.3 | 1.9 | 1.0 | 0.5 | -0.6 | 0.4 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 378 | 834 | 1,010 | 1,320 | 1,340 | 1,051 | 2,609 | 2,269 | 2,063 |
Growth Revenue Growth% | 120.7 | 21.1 | 30.8 | 1.5 | -21.6 | 148.1 | -13.0 | -21.3 | |
| 206 | 452 | 569 | 741 | 774 | 646 | 1,811 | 1,842 | 1,832 | |
| 172 | 382 | 440 | 579 | 567 | 406 | 797 | 427 | 231 | |
OPM OPM% | 45.4 | 45.8 | 43.6 | 43.9 | 42.3 | 38.6 | 30.6 | 18.8 | 11.2 |
| 1 | 66 | 68 | 133 | 46 | 62 | 53 | 5 | 8 | |
Interest Expense Interest ExpenseCr | 3 | 20 | 9 | 6 | 5 | 7 | 41 | 37 | 33 |
Depreciation DepreciationCr | 12 | 24 | 32 | 39 | 48 | 55 | 167 | 187 | 198 |
PBT PBTCr | 158 | 405 | 468 | 668 | 560 | 406 | 643 | 207 | 7 |
| 49 | 88 | 105 | 214 | 148 | 105 | 158 | 57 | 12 | |
PAT PATCr | 109 | 317 | 362 | 454 | 411 | 300 | 484 | 150 | -6 |
Growth PAT Growth% | 190.1 | 14.3 | 25.2 | -9.4 | -27.0 | 61.3 | -69.0 | -101.5 | |
NPM NPM% | 28.9 | 38.0 | 35.9 | 34.4 | 30.7 | 28.6 | 18.6 | 6.6 | -0.3 |
| 8.6 | 12.5 | 14.2 | 17.8 | 16.2 | 11.8 | 12.8 | 4.7 | 1.2 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 378 | 834 | 1,010 | 1,320 | 1,340 | 1,051 | 2,609 | 2,269 | 2,063 |
Growth Revenue Growth% | 120.7 | 21.1 | 30.8 | 1.5 | -21.6 | 148.1 | -13.0 | -21.3 | |
| 206 | 452 | 569 | 741 | 774 | 646 | 1,811 | 1,842 | 1,832 | |
| 172 | 382 | 440 | 579 | 567 | 406 | 797 | 427 | 231 | |
OPM OPM% | 45.4 | 45.8 | 43.6 | 43.9 | 42.3 | 38.6 | 30.6 | 18.8 | 11.2 |
| 1 | 66 | 68 | 133 | 46 | 62 | 53 | 5 | 8 | |
Interest Expense Interest ExpenseCr | 3 | 20 | 9 | 6 | 5 | 7 | 41 | 37 | 33 |
Depreciation DepreciationCr | 12 | 24 | 32 | 39 | 48 | 55 | 167 | 187 | 198 |
PBT PBTCr | 158 | 405 | 468 | 668 | 560 | 406 | 643 | 207 | 7 |
| 49 | 88 | 105 | 214 | 148 | 105 | 158 | 57 | 12 | |
PAT PATCr | 109 | 317 | 362 | 454 | 411 | 300 | 484 | 150 | -6 |
Growth PAT Growth% | 190.1 | 14.3 | 25.2 | -9.4 | -27.0 | 61.3 | -69.0 | -101.5 | |
NPM NPM% | 28.9 | 38.0 | 35.9 | 34.4 | 30.7 | 28.6 | 18.6 | 6.6 | -0.3 |
| 8.6 | 12.5 | 14.2 | 17.8 | 16.2 | 11.8 | 12.8 | 4.7 | 1.2 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 13 | 13 | 25 | 25 | 25 | 25 | 25 | 38 | 38 |
Reserves ReservesCr | 578 | 832 | 1,155 | 1,502 | 1,710 | 2,025 | 3,604 | 3,873 | 3,874 |
| 158 | 200 | 220 | 210 | 159 | 107 | 705 | 646 | 865 | |
| 35 | 128 | 74 | 92 | 72 | 97 | 983 | 1,050 | 828 | |
| 783 | 1,173 | 1,474 | 1,830 | 1,966 | 2,254 | 5,481 | 5,730 | 5,680 | |
| 390 | 392 | 565 | 1,128 | 1,011 | 1,263 | 1,758 | 1,796 | 1,717 | |
| 393 | 781 | 910 | 702 | 955 | 991 | 3,723 | 3,933 | 3,939 | |
| 783 | 1,173 | 1,474 | 1,830 | 1,966 | 2,254 | 5,481 | 5,730 | 5,680 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 13 | 13 | 25 | 25 | 25 | 25 | 25 | 38 | 38 |
Reserves ReservesCr | 578 | 832 | 1,155 | 1,502 | 1,710 | 2,025 | 3,604 | 3,873 | 3,874 |
| 158 | 200 | 220 | 210 | 159 | 107 | 705 | 646 | 865 | |
| 35 | 128 | 74 | 92 | 72 | 97 | 983 | 1,050 | 828 | |
| 783 | 1,173 | 1,474 | 1,830 | 1,966 | 2,254 | 5,481 | 5,730 | 5,680 | |
| 390 | 392 | 565 | 1,128 | 1,011 | 1,263 | 1,758 | 1,796 | 1,717 | |
| 393 | 781 | 910 | 702 | 955 | 991 | 3,723 | 3,933 | 3,939 | |
| 783 | 1,173 | 1,474 | 1,830 | 1,966 | 2,254 | 5,481 | 5,730 | 5,680 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| 50 | 407 | 383 | 330 | 457 | 358 | 673 | 368 | |
| -65 | -413 | -311 | -136 | -195 | -362 | -390 | -255 | |
| 26 | 7 | -76 | -156 | -242 | -14 | -327 | -165 | |
Net Cash Flow Net Cash FlowCr | 11 | 1 | -5 | 37 | 20 | -18 | -44 | -51 |
Free Cash Flow Free Cash FlowCr | -6 | 304 | 272 | 255 | 171 | 307 | 357 | 169 |
CFO To PAT CFO To PAT% | 46.1 | 128.4 | 105.6 | 72.7 | 111.2 | 119.4 | 139.1 | 245.3 |
CFO To EBITDA CFO To EBITDA% | 29.4 | 106.6 | 86.8 | 57.0 | 80.7 | 88.3 | 84.5 | 86.3 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| 50 | 407 | 383 | 330 | 457 | 358 | 673 | 368 | |
| -65 | -413 | -311 | -136 | -195 | -362 | -390 | -255 | |
| 26 | 7 | -76 | -156 | -242 | -14 | -327 | -165 | |
Net Cash Flow Net Cash FlowCr | 11 | 1 | -5 | 37 | 20 | -18 | -44 | -51 |
Free Cash Flow Free Cash FlowCr | -6 | 304 | 272 | 255 | 171 | 307 | 357 | 169 |
CFO To PAT CFO To PAT% | 46.1 | 128.4 | 105.6 | 72.7 | 111.2 | 119.4 | 139.1 | 245.3 |
CFO To EBITDA CFO To EBITDA% | 29.4 | 106.6 | 86.8 | 57.0 | 80.7 | 88.3 | 84.5 | 86.3 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 2,564 | 12,611 | 15,731 | 12,033 | 17,224 | 29,524 | 11,550 | 17,394 | |
Price To Earnings Price To Earnings | 8.1 | 34.8 | 34.7 | 29.3 | 57.3 | 60.6 | 64.5 | 366.6 | |
Price To Sales Price To Sales | 3.1 | 12.5 | 11.9 | 9.0 | 16.4 | 11.3 | 5.1 | 8.4 | |
Price To Book Price To Book | 3.0 | 10.7 | 10.3 | 6.9 | 8.4 | 8.1 | 3.0 | 4.5 | |
EV To EBITDA EV To EBITDA | 7.2 | 28.9 | 27.2 | 21.2 | 42.5 | 37.5 | 27.9 | 77.6 | |
GPM GPM% | 59.1 | 60.1 | 56.9 | 56.6 | 56.3 | 57.3 | 56.4 | 53.0 | 53.0 |
OPM OPM% | 45.4 | 45.8 | 43.6 | 43.9 | 42.3 | 38.6 | 30.6 | 18.8 | 11.2 |
NPM NPM% | 28.9 | 38.0 | 35.9 | 34.4 | 30.7 | 28.6 | 18.6 | 6.6 | -0.3 |
ROCE ROCE% | 23.9 | 41.2 | 36.0 | 41.5 | 31.3 | 19.5 | 16.6 | 5.7 | 1.0 |
ROE ROE% | 18.5 | 37.5 | 30.7 | 29.7 | 23.7 | 14.6 | 13.3 | 3.8 | -0.1 |
ROA ROA% | 14.0 | 27.0 | 24.6 | 24.8 | 20.9 | 13.3 | 8.8 | 2.6 | -0.1 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 2,564 | 12,611 | 15,731 | 12,033 | 17,224 | 29,524 | 11,550 | 17,394 | |
Price To Earnings Price To Earnings | 8.1 | 34.8 | 34.7 | 29.3 | 57.3 | 60.6 | 64.5 | 366.6 | |
Price To Sales Price To Sales | 3.1 | 12.5 | 11.9 | 9.0 | 16.4 | 11.3 | 5.1 | 8.4 | |
Price To Book Price To Book | 3.0 | 10.7 | 10.3 | 6.9 | 8.4 | 8.1 | 3.0 | 4.5 | |
EV To EBITDA EV To EBITDA | 7.2 | 28.9 | 27.2 | 21.2 | 42.5 | 37.5 | 27.9 | 77.6 | |
GPM GPM% | 59.1 | 60.1 | 56.9 | 56.6 | 56.3 | 57.3 | 56.4 | 53.0 | 53.0 |
OPM OPM% | 45.4 | 45.8 | 43.6 | 43.9 | 42.3 | 38.6 | 30.6 | 18.8 | 11.2 |
NPM NPM% | 28.9 | 38.0 | 35.9 | 34.4 | 30.7 | 28.6 | 18.6 | 6.6 | -0.3 |
ROCE ROCE% | 23.9 | 41.2 | 36.0 | 41.5 | 31.3 | 19.5 | 16.6 | 5.7 | 1.0 |
ROE ROE% | 18.5 | 37.5 | 30.7 | 29.7 | 23.7 | 14.6 | 13.3 | 3.8 | -0.1 |
ROA ROA% | 14.0 | 27.0 | 24.6 | 24.8 | 20.9 | 13.3 | 8.8 | 2.6 | -0.1 |
| Market CapitalizationMkt CapCr | 18,318 | 17,716 | 17,386 | 11,652 | 10,212 | 9,141 | 5,618 |
| Close PriceClose₹ | 936.60 | 1,440.70 | 454.40 | 556.90 | 1,589.20 | 1,008.00 | 191.40 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 55.09 | 26.42 | 366.45 | 41.68 | 75.35 | 35.61 | 27.66 |
| Price To SalesPS | 9.94 | 6.60 | 8.43 | 9.96 | 11.75 | 4.23 | 2.04 |
| RevenueRevenueCr | 1,842 | 2,684 | 2,063 | 1,170 | 869 | 2,161 | 2,751 |
| Revenue Growth TTMRev Gr TTM% | 37.3% | 8.2% | -21.3% | 4.0% | 13.4% | 26.8% | |
| PAT Growth TTMPAT Gr TTM% | 142.2% | 26.3% | -101.5% | -13.6% | 7.1% | 75.4% |
| Market CapitalizationMkt CapCr | 18,318 | 17,716 | 17,386 | 11,652 | 10,212 | 9,141 | 5,618 |
| Close PriceClose₹ | 936.60 | 1,440.70 | 454.40 | 556.90 | 1,589.20 | 1,008.00 | 191.40 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 55.09 | 26.42 | 366.45 | 41.68 | 75.35 | 35.61 | 27.66 |
| Price To SalesPS | 9.94 | 6.60 | 8.43 | 9.96 | 11.75 | 4.23 | 2.04 |
| RevenueRevenueCr | 1,842 | 2,684 | 2,063 | 1,170 | 869 | 2,161 | 2,751 |
| Revenue Growth TTMRev Gr TTM% | 37.3% | 8.2% | -21.3% | 4.0% | 13.4% | 26.8% | |
| PAT Growth TTMPAT Gr TTM% | 142.2% | 26.3% | -101.5% | -13.6% | 7.1% | 75.4% |